Investigation of the MERS-CoV S protein mutations could aid in the development of pan-β-CoV vaccines that can target SARS-CoV-2 for current COVID-19 pandemic as well as the putative MERS-CoV-2 or SARS-CoV-3-like coronavirus for the future pandemics. This evidence concerns the gene PROS1 and COVID-19.